StockMacro
Menu

Gsa Capital Partners LLP

Institutional investment manager (13F filer) CIK 1362033Name as filed: GSA CAPITAL PARTNERS LLPIts filings on EDGARAll funds

Measures activity, not value. Not investment advice.

Reported $2K in 1,675 companies we cover at the end of Q3 2026; opened 584 positions and sold out of 468; largest new position: Veritone, $0.

Reported value, Q3 2026 The total market value the manager reported on Form 13F for the quarter end, in dollars, including companies outside our coverage. 13F lists long positions in US-listed shares and options only, and is filed up to 45 days after the quarter ends.
$2K
Positions in companies we cover
1,675
Their share of the reported value
100%
Report filed
16 Nov 2026
Reported value per quarter, Q4 2016 to Q3 2026
Q4 2016: $1.7B, 958 positionsQ1 2017: $1.9B, 985 positionsQ2 2017: $1.5B, 957 positionsQ3 2017: $1.5B, 923 positionsQ4 2017: $1.6B, 893 positionsQ1 2018: $1.9B, 961 positionsQ2 2018: $2.0B, 1,008 positionsQ3 2018: $1.8B, 999 positionsQ4 2018: $866.7M, 814 positionsQ1 2019: $986.9M, 894 positionsQ2 2019: $892.9M, 904 positionsQ3 2019: $739.2M, 916 positionsQ4 2019: $858.5M, 961 positionsQ1 2020: $398.8M, 681 positionsQ2 2020: $179.3M, 374 positionsQ3 2020: $599.6M, 871 positionsQ4 2020: $611.4M, 778 positionsQ1 2021: $602.7M, 711 positionsQ2 2021: $888.7M, 909 positionsQ3 2021: $981.6M, 955 positionsQ4 2021: $796.1M, 977 positionsQ1 2022: $745.0M, 974 positionsQ2 2022: $666.3M, 971 positionsQ3 2022: $752.2M, 1,110 positionsQ4 2022: $0, 1,064 positionsQ1 2023: $0, 1,053 positionsQ2 2023: $13K, 1,086 positionsQ3 2023: $0, 1,121 positionsQ4 2023: $0, 1,081 positionsQ1 2024: $0, 1,194 positionsQ2 2024: $0, 1,251 positionsQ3 2024: $0, 1,277 positionsQ4 2024: $0, 1,309 positionsQ1 2025: $0, 1,365 positionsQ2 2025: $0, 1,472 positionsQ3 2025: $0, 1,384 positionsQ4 2025: $0, 1,445 positionsQ1 2026: $17, 1,514 positionsQ2 2026: $0, 1,559 positionsQ3 2026: $2K, 1,675 positions

Q4 2016Highest $2.0BQ3 2026

Every quarter
QuarterReported valuePositions we coverFiledReport
Q3 2026$2K1,67516 Nov 202613F-HR
Q2 2026$01,5596 Aug 202613F-HR
Q1 2026$171,5148 May 202613F-HR
Q4 2025$01,4456 Feb 202613F-HR
Q3 2025$01,3847 Nov 202513F-HR
Q2 2025$01,47222 Jul 202513F-HR
Q1 2025$01,3658 May 202513F-HR
Q4 2024$01,3097 Feb 202513F-HR
Q3 2024$01,2775 Nov 202413F-HR
Q2 2024$01,25115 Aug 202413F-HR
Q1 2024$01,1943 May 202413F-HR
Q4 2023$01,08116 Feb 202413F-HR
Q3 2023$01,12115 Nov 202313F-HR
Q2 2023$13K1,08614 Aug 202313F-HR
Q1 2023$01,05312 May 202313F-HR
Q4 2022$01,06413 Feb 202313F-HR
Q3 2022$752.2M1,11014 Nov 202213F-HR
Q2 2022$666.3M9719 Aug 202213F-HR
Q1 2022$745.0M97411 May 202213F-HR
Q4 2021$796.1M97714 Feb 202213F-HR
Q3 2021$981.6M95512 Nov 202113F-HR
Q2 2021$888.7M9095 Aug 202113F-HR
Q1 2021$602.7M71110 May 202113F-HR
Q4 2020$611.4M7783 Feb 202113F-HR
Q3 2020$599.6M8716 Nov 202013F-HR
Q2 2020$179.3M37411 Aug 202013F-HR
Q1 2020$398.8M68112 May 202013F-HR
Q4 2019$858.5M96112 Feb 202013F-HR
Q3 2019$739.2M91612 Nov 201913F-HR
Q2 2019$892.9M9046 Aug 201913F-HR
Q1 2019$986.9M89415 May 201913F-HR
Q4 2018$866.7M81412 Feb 201913F-HR
Q3 2018$1.8B99913 Nov 201813F-HR
Q2 2018$2.0B1,0089 Aug 201813F-HR
Q1 2018$1.9B96111 May 201813F-HR
Q4 2017$1.6B89314 Feb 201813F-HR
Q3 2017$1.5B92320 Nov 201713F-HR
Q2 2017$1.5B95711 Aug 201713F-HR
Q1 2017$1.9B98515 May 201713F-HR
Q4 2016$1.7B95814 Feb 201713F-HR
Q3 2016$1.9B95714 Nov 201613F-HR
Q2 2016$1.8B9504 Aug 201613F-HR
Q1 2016$1.6B88711 May 201613F-HR
Q4 2015$2.0B9949 Feb 201613F-HR
Q3 2015$2.0B89513 Nov 201513F-HR
Q2 2015$2.6B1,01814 Aug 201513F-HR
Q1 2015$2.5B1,09914 May 201513F-HR
Q4 2014$1.4B8715 Feb 201513F-HR
Q3 2014$1.9B8586 Nov 201413F-HR
Q2 2014$2.2B9178 Aug 201413F-HR
Q1 2014$1.4B79114 May 201413F-HR
Q4 2013$1.3B83312 Feb 201413F-HR
Q3 2013$1.2B77114 Nov 201313F-HR
Q2 2013$843.1M62613 Aug 201313F-HR

Holdings at the end of Q3 2026

Largest 50 of 1,675, by value
#CompanySharesValue% of portfolio The position's value as a share of the reported value of the whole report. % of company Shares held as a share of the company's shares outstanding (latest financial report). Change vs Q2 2026
1Cardinal Health CAH11K$2K100%0.00%+6,031122%
2Heron Therapeutics HRTX5.5M$02.9%+4.4M425%
3aTyr Pharma ATYR3.4M$0134%-34K-1.00%
4Standard BioTools LAB3.0M$00.77%+1.8M156%
5SelectQuote SLQT2.9M$01.6%+1.6M120%
6DocGo DCGO1.4M$01.5%+439K44%
7SmartRent SMRT1.4M$00.71%+523K63%
8CHEGG CHGG1.3M$01.1%+449K54%
9EVgo EVGO1.2M$0+622K110%
10Veritone VERI1.1M$00.94%New
11Tenaya Therapeutics TNYA1.1M$00.48%-1.6M-59%
12Hyperscale Data GPUS1.1M$0New
13Rani Therapeutics RANI1.0M$0+800K320%
14Blink Charging BLNK1.0M$00.70%+950K1456%
15Microvast MVST1.0M$00.26%New
16Blend Labs BLND980K$0+436K80%
17Soluna SLNH897K$00.35%+757K543%
18MaxCyte MXCT891K$00.86%+335K60%
19Eightco ORBS867K$00.23%New
20Nextdoor NXDR850K$0+136K19%
21Vistagen Therapeutics VTGN820K$01.8%+766K1403%
22Akebia Therapeutics AKBA783K$00.28%+698K821%
23KinderCare Learning Companies KLC782K$00.66%+338K76%
24Babcock & Wilcox Enterprises BW755K$00.52%+561K289%
25Inter INTR739K$0+527K248%
26Definitive Healthcare DH733K$00.68%+207K39%
27Telos TLS713K$00.97%-160K-18%
28NET Power NPWR687K$0-165K-19%
29Teads TEAD677K$00.69%+116K21%
30PureCycle Technologies PCT667K$00.33%New
31Jeld-Wen JELD651K$00.75%+190K41%
32Gain Therapeutics GANX635K$01.4%+2,5850.41%
33Ready Capital RC627K$00.39%+138K28%
34MDxHealth SA MDXH593K$01.2%+111K23%
35Mobileye MBLY586K$00.23%+352K150%
36Franklin Street Properties FSP583K$00.56%+84K17%
37Arq ARQ571K$01.3%+223K64%
38eHealth EHTH556K$01.7%+224K68%
39Caribou Biosciences CRBU552K$00.51%+88K19%
40Rekor Systems REKR550K$00.40%New
41Allogene Therapeutics ALLO543K$00.16%+257K90%
42Zevia PBC ZVIA541K$0+133K33%
43Cardiff Oncology CRDF538K$00.69%+364K210%
44Frontier ULCC536K$00.23%-17K-3.1%
45iHeartMedia IHRT529K$0+130K33%
46Apartment Investment and Management AIV522K$00.36%-19K-3.6%
47TScan Therapeutics TCRX511K$0-37K-6.8%
48AirSculpt Technologies AIRS499K$00.67%+73K17%
49Quanterix QTRX495K$01.0%+84K21%
50Under Armour UAA492K$0+108K28%

Bought and sold in Q3 2026

Compared with its Q2 2026 report. Share changes valued at the quarter-end price.

Biggest decreases 0

None.

Sector mix

Share of the value in companies we cover
SectorQ3 2026As a bar
Wholesale Trade100%
Financials0.00%
Automotive0.00%
Consumer Staples0.00%
Manufacturing0.00%
Agriculture, Forestry & Fishing0.00%
Energy0.00%
Retail0.00%
Health Care0.00%
Not classified0.00%
Aerospace & Defense0.00%
Construction0.00%
Services0.00%
Technology0.00%
Real Estate0.00%
Consumer Discretionary0.00%
Transportation0.00%
Communication Services0.00%
Mining0.00%
Materials0.00%
Utilities0.00%

From Form 13F: long positions in US-listed shares and options at the quarter end, filed up to 45 days later; short positions are not reported. Values are in dollars (reports filed before 2023 were in thousands and are converted). Measures activity, not value. Not investment advice.